 |
|
Adolescents With Depression—Reply
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In Reply: We appreciate the opportunity to clarify the results of TADS. Drs Antonuccio and Burns interpret our results as showing that fluoxetine offers no significant benefit over placebo, arguing (we believe incorrectly) that exercise is a placebo treatment and is somehow preferable to any of the TADS treatments. Drs Rifkin and Rifkin conclude that for the study population as a whole CBT plus fluoxetine offers little or no advantage over fluoxetine alone. In response, we note that TADS used the rate of improvement and 12-week outcome on the Children’s Depression Rating Scale, the rate of improvement and 12-week outcome on the RADS, and percentage of patients much or very much improved on the CGI scale. Fluoxetine in combination with CBT was superior to placebo and to CBT alone on all 5 measures. Combined treatment was superior to fluoxetine on 2 measures. Fluoxetine alone was superior to placebo on 3 . . . [Full Text of this Article]
John S. March, MD, MPH
for the TADS Team
jsmarch@acpub.duke.edu
Duke University Medical Center
Durham, NC
RELATED ARTICLES
Adolescents With Depression
David Antonuccio and David Burns
JAMA. 2004;292(21):2577.
EXTRACT
| FULL TEXT
Adolescents With Depression
Arthur Rifkin and William Rifkin
JAMA. 2004;292(21):2577-2578.
EXTRACT
| FULL TEXT
Adolescents With Depression
Bernard J. Carroll
JAMA. 2004;292(21):2578.
EXTRACT
| FULL TEXT
Adolescents With Depression
Jeffrey A. Bridge and David A. Brent
JAMA. 2004;292(21):2578.
EXTRACT
| FULL TEXT
Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With Depression: Treatment for Adolescents With Depression Study (TADS) Randomized Controlled Trial
Treatment for Adolescents With Depression Study Team
JAMA. 2004;292(7):807-820.
ABSTRACT
| FULL TEXT
|
